Latest Regenerative Pediatric News

Researchers will test if umbilical cord stem cell infusions can safely reduce lung disease in extremely premature infants.
Longeveron will evaluate if it's stem cell candidate, laromestrocel, could target pediatric dilated cardiomyopathy
The company uses iPSCs to create a replica environment for maturing eggs ex vivo, and the data looks promising as they roll into Phase 3.
The company plans on moving to Phase 2 later this year, hopefully supporting a BLA in the near future.

Stay updated on Regenerative Medicine